Pulmatrix, Inc.
Pulmatrix, Inc. (PULM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pulm · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pulmatrix, Inc.You PULM | $5M | N/A | — | — |
 Aditxt, Inc. ADTX | $0M | N/A | — | -$1116.70 |
 Aspire Biopharma Holdings, Inc. ASBP | $1M | N/A | — | -$16.38 |
 Curis, Inc. CRIS | $6M | N/A | — | -$0.06 |
 Citius Pharmaceuticals, Inc. CTXR | $7M | N/A | — | -$3.38 |
 Daré Bioscience, Inc. DARE | $18M | N/A | — | -$0.12 |
 FibroBiologics, Inc. Common Stock FBLG | $2M | N/A | — | -$8.35 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pulmatrix, Inc. (PULM) measures how much investors pay for each dollar of the company's trailing earnings. PULM's current PE ratio of N/A is calculated by dividing its stock price of $1.42 by its TTM earnings per share of —.
Frequently asked questions
PULM pe ratio · 6 questionsPULM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.42 and TTM EPS of —. Data sourced from Financial Modeling Prep via PULM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pulmatrix, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09